Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

151 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A randomized trial to evaluate the preventive effect of lafutidine on chemotherapy-induced peripheral neuropathy in patients treated with carboplatin and paclitaxel for lung cancer.
Cho K, Saikawa H, Hashimoto T, Katagiri H, Owada Y, Yakuwa K, Fujimura I, Utsumi Y, Akiyama M, Nagashima H, Takahashi F, Maemondo M. Cho K, et al. Among authors: maemondo m. Ann Palliat Med. 2023 Nov;12(6):1136-1145. doi: 10.21037/apm-23-90. Epub 2023 Sep 18. Ann Palliat Med. 2023. PMID: 37731302 Free article. Clinical Trial.
Characteristics and prognostic analysis of patients with detected KRAS mutations in resected lung adenocarcinomas by peptide nucleic acid-locked nucleic acid polymerase chain reaction (PNA-LNA PCR) clamp method.
Hashimoto T, Owada Y, Katagiri H, Yakuwa K, Tyo K, Sugai M, Fuzimura I, Utsumi Y, Akiyama M, Nagashima H, Terasaki H, Yanagawa N, Saito H, Sugai T, Maemondo M. Hashimoto T, et al. Among authors: maemondo m. Transl Lung Cancer Res. 2023 Sep 28;12(9):1862-1875. doi: 10.21037/tlcr-23-15. Epub 2023 Sep 15. Transl Lung Cancer Res. 2023. PMID: 37854155 Free PMC article.
[No title available]
[No authors listed] [No authors listed] PMID: 38082162
Prognostic and predictive value of CD163 expression and the CD163/CD68 expression ratio for response to adjuvant chemotherapy in patients with surgically resected lung squamous cell carcinoma.
Yanagawa N, Shikanai S, Sugai M, Koike Y, Asai Y, Tanji T, Sugimoto R, Osakabe M, Uesugi N, Saito H, Maemondo M, Sugai T. Yanagawa N, et al. Among authors: maemondo m. Thorac Cancer. 2023 Jul;14(20):1911-1920. doi: 10.1111/1759-7714.14937. Epub 2023 May 20. Thorac Cancer. 2023. PMID: 37208929 Free PMC article.
Significance of Persistent Systemic Support in the Clinical Course of Delayed Post-hypoxic Leukoencephalopathy Following Severe Coronavirus Disease 2019.
Kawasaki J, Mato N, Fujii H, Miura K, Mashiko T, Katayama S, Yamanouchi Y, Sato M, Takasaki T, Takigami A, Hisata S, Nunomiya S, Hagiwara K, Maemondo M. Kawasaki J, et al. Among authors: maemondo m. Intern Med. 2024 Apr 15;63(8):1167-1172. doi: 10.2169/internalmedicine.1412-22. Epub 2024 Feb 1. Intern Med. 2024. PMID: 38296478 Free PMC article.
First-line nivolumab plus ipilimumab with or without chemotherapy for Japanese patients with non-small cell lung cancer: LIGHT-NING study.
Imai H, Kijima T, Azuma K, Kishi K, Saito H, Yamaguchi T, Tanizaki J, Yoneshima Y, Fujita K, Watanabe S, Kitazono S, Fukuhara T, Hataji O, Toi Y, Mizutani H, Hamakawa Y, Maemondo M, Ohsugi T, Suzuki K, Horinouchi H, Ohe Y. Imai H, et al. Among authors: maemondo m. Jpn J Clin Oncol. 2024 Apr 6;54(4):452-462. doi: 10.1093/jjco/hyad195. Jpn J Clin Oncol. 2024. PMID: 38271158 Free PMC article.
151 results